Skip to main content

stock

RNAC · Cartesian Therapeutics, Inc.

What Cartesian Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live RNAC price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on RNAC.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
30,255,352 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-47.7%

Health

Current ratio
7.5x
Debt/equity
—

Deep value

NCAV
-$290.24M
NCAV per share
-$9.59
Price/NCAV
Locked
NNWC
-$296.10M
NNWC per share
-$9.79
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$0—Gross profit: unreported by this company.-$29.16M$15.77M
10-Q filed 2026-08-06
2026-03-31$0—Gross profit: unreported by this company.-$26.50M-$39.18M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$0—Gross profit: unreported by this company.-$78.64M-$92.58M
DEF 14A filed 2026-04-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$0—Gross profit: unreported by this company.-$21.07M-$35.90M
10-Q filed 2025-11-06
2025-06-30$0—Gross profit: unreported by this company.-$21.81M$15.89M
10-Q filed 2026-08-06
2025-03-31$400,000—Gross profit: unreported by this company.-$21.89M-$17.71M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31-$836,000—Gross profit: unreported by this company.-$26.73M-$10.25M
DEF 14A filed 2026-04-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$17.57M-$24.18M
10-Q filed 2025-11-06
Assets
$318.63M
Equity
-$125.23M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$400,000-$143.41M-$130.30M-$79.39M
2024-12-31$38.27M-$43.90M-$77.42M-$32.77M
2023-12-31$26.00M-$86.42M-$219.71M-$51.37M
2022-12-31$110.78M$14.54M$35.38M-$32.83M
2021-12-31$85.08M-$4.60M-$25.69M-$61.47M
2020-12-31$16.60M-$56.82M-$68.88M$34.07M
2019-12-31$6.68M-$52.45M-$55.35M-$51.48M
2018-12-31$903,000-$65.02M-$65.34M-$60.05M
2017-12-31$207,000-$63.78M-$65.32M-$52.76M
2016-12-31$8.08M-$34.67M-$36.21M-$20.34M

Company filings

events

  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Sep 298-K
  • Results

    Results
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 178-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jun 98-K
  • Material agreement, New debt, Unregistered share sale, Executive or director change, Regulation FD disclosure

    Material agreementNew debtUnregistered share saleExecutive or director changeRegulation FD disclosure
    May 268-K
  • Results

    Results
    Apr 308-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%New

All funds

News

Stories that named RNAC, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about RNAC.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about RNAC.

nakagai

Signals on RNAC come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the RNAC board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Cartesian Therapeutics, Inc. (RNAC): SEC filings, financials and insider trades · Nakagai